Author

Shannon R. Esswein

California Institute of TechnologyORCID 0000-0002-5142-0190Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:protein structure· 1 Approach:statistical model· 1

Frequent Co-Authors

Andrey G. MalyutiniD· 1 shared Anthony P. WestiD· 1 shared Christopher O. BarnesiD· 1 shared Claudia A. JetteiD· 1 shared Davide F. RobbianiiD· 1 shared Harry B. GristickiD· 1 shared Kathryn E. Huey‐TubmaniD· 1 shared Kim-Marie A. DamiD· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Andrey G. MalyutinORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Structural classification of neutralizing antibodies against the SARS-CoV-2 spike receptor-binding domain suggests vaccine and therapeutic strategies

Christopher O. Barnes, Claudia A. Jette, Morgan E. Abernathy, Kim-Marie A. Dam, Shannon R. Esswein, Harry B. Gristick, Andrey G. Malyutin, Naima G. Sharaf, Kathryn E. Huey‐Tubman, Yu Erica Lee, Davide F. Robbiani, Michel C. Nussenzweig, Anthony P. West, Pamela J. Björkman

The paper classifies neutralizing antibodies against SARS-CoV-2 spike RBD based on structure, identifying binding modes and implications for vaccine and therapeutic strategies.

Nature · Oct 12, 2020Peer-reviewedMolecular Biology